ClinicalTrials.gg
Not yet recruitingNCT07835165CRANIODIETUpdated Sep 22, 2026

A Comparative Study Evaluating the Impact of Intensive Dietary Care on Weight Change and Biological Parameters in Patients Who Underwent Surgery for Craniopharyngioma During the First Postoperative Year

An interventional study of Intensive dietary care in Craniopharyngioma, sponsored by Assistance Publique Hopitaux De Marseille. Not yet recruiting. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-09-22.

Sponsored by Assistance Publique Hopitaux De Marseille · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Non-randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Craniopharyngiomas are rare benign tumors that develop in the hypothalamic-pituitary region. Their prevalence is estimated at approximately 1 in 50,000 people in France.

The main symptoms associated with this condition are headaches and visual, neurological, and hormonal disorders. These symptoms appear when the tumors are large enough to compress adjacent structures (optic chiasm, pituitary gland, etc.).

The current standard treatment is surgical removal via endonasal approach or craniotomy, most often combined with adjuvant radiotherapy. One of the common postoperative complications is significant and rapid weight gain leading to obesity, which occurs in 26 to 61% of cases depending on the type of surgery.

These disorders can cause impulsive eating, hyperphagia, and persistent hunger, leading to deleterious metabolic consequences with an increase in comorbidities (diabetes, cardiovascular disease, joint problems, abnormal blood tests, asthma, etc.). They can also have psychosocial consequences, with a significant risk of professional and personal activity cessation during the first year after surgery due to asthenia and other possible postoperative complications (dizziness, discomfort, etc.).

In addition, this surgery alters the functioning of the pituitary gland, requiring lifelong hormone supplementation, particularly with hydrocortisone, a hormone that is essential for stress management and energy release. The optimal doses for these replacement therapies are difficult to determine. They are most often found at the end of the first year after surgery, which can then allow for a gradual resumption of normal social and professional activities and better control of health and dietary advice. This first year after surgery is therefore a pivotal year in the possible development of obesity in these patients, which justifies the importance of intensive dietary care offered to these patients as early as possible.

The investigators hypothesise that intensive dietary care could prevent weight gain and an increase in comorbidities in patients who have undergone surgery for craniopharyngioma.

The primary objective of this study is to evaluate the impact of intensive dietary care (intervention group in a prospective phase) versus usual care (control group in a retrospective pre-intervention phase) on the relative weight change in patients one year after the first resection of a craniopharyngioma.

The primary endpoint is the relative change in weight at 1 year post-surgery, i.e. the difference between the weight recorded at the last dietary consultation 1 year post-surgery and that recorded at the preoperative consultation, relative to the weight recorded at the preoperative consultation.

This study is a comparative, quasi-experimental before/after study, with a pre-control phase corresponding to patients who have undergone surgery for their craniopharyngioma and have received standard dietary management versus an interventional 'after' phase, corresponding to patients who will undergo surgery for their craniopharyngioma and who will receive intensive dietary management. The study is single-centre, with 50 patients to be recruited in the control group and 25 in the intervention group.

The expected results are to assess whether intensive dietary care (versus standard care) can limit weight gain in the year following the first removal of a craniopharyngioma, as well as its impact on socio-professional activities and the onset of comorbidities.

02

Conditions studied

  • Craniopharyngioma

Browse trials for

03

In context

Craniopharyngioma

76 studies on the registry are indexed under Craniopharyngioma; 19 are open to participants now.

This study's planned enrollment of 75 is above the median of 40 across 49 interventional studies indexed under Craniopharyngioma.

Browse Craniopharyngioma studies →

Lead sponsor

Assistance Publique Hopitaux De Marseille is the lead sponsor of 702 studies on the registry; 139 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Retrospective group:

    • Male or female patients aged between 18 and 70 (outside this age range, the criteria are different).
    • Patients with craniopharyngioma who underwent initial craniopharyngioma resection surgery in Prof. Dufour's neurosurgery department at La Timone Hospital (APHM) between 1 January 2017 and 31 December 2021.
    • Weight data available at 15 days, 3 months and 1 year after their initial surgery in the Electronic Patient Record (EPR).
    • Patient informed and not opposed to the reuse of their data.
  • Prospective group:

    • Male or female patients aged between 18 and 70 (outside this age range, the BMI criteria are different).
    • Patients with craniopharyngioma in the immediate preoperative period of a first craniopharyngioma resection scheduled to be performed in Prof. Dufour's neurosurgery department at La Timone Hospital (APHM).
    • Patients affiliated with or covered by a social security scheme.
    • Patients who have signed a free, written and form.
    • Patients who have scales at home and are able to weigh themselves.

Exclusion criteria

Exclusion Criteria:

  • - Retrospective group:

    • Patients with type 1 diabetes due to possible weight variation linked to a potential imbalance in diabetes.
    • Patients with a history of bariatric surgery, whose weight loss could be skewed by the surgical procedure (low food intake) and by changes in the secretion of the hormones leptin (satiety hormone) and ghrelin (hunger hormone), which are possible confounding factors.
    • Patients with recurrent craniopharyngioma who have a history of craniopharyngioma surgery or radiotherapy treatment for this tumour. These patients may already have hypothalamic disorders, eating disorders or weight gain following the initial removal of the craniopharyngioma.
    • Adult patients under guardianship or curatorship. Pregnant or breastfeeding women.
  • Prospective group:

    • Patients with memory disorders that prevent them from following dietary guidelines.
    • Patients with type 1 diabetes due to possible weight variation linked to a potential imbalance in diabetes.
    • Patients with a history of bariatric surgery, whose weight loss could be skewed by the surgical procedure (low food intake) and by changes in the secretion of the hormones leptin (satiety hormone) and ghrelin (hunger hormone), which are possible confounding factors.
    • Patients with recurrent craniopharyngioma who have a history of craniopharyngioma surgery or radiotherapy treatment for this tumour. These patients may already have hypothalamic disorders, eating disorders or weight gain following the initial removal of the craniopharyngioma.
    • Adult patients under guardianship or curatorship.
    • Pregnant or breastfeeding women.
    • Pregnancy (self-reported) or breastfeeding and all other categories of persons benefiting from special protection under the French Public Health Code (CSP): patients under legal protection, patients hospitalised without consent, patients admitted to social or health facilities for care and not for research, and patients in emergency situations.
    • Patients unable to give or who refuse to participate in the study.

Patient already participating in an interventional study on craniopharyngioma.

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
75 participants (estimated)

Study arms

  • No intervention
    Retrospective group
  • Experimental
    Prospective group

    Other: Intensive dietary care

Interventions

  • OtherIntensive dietary care

    Intensive dietary care following surgery for a craniopharyngioma with 3 visits 2 weeks prior surgery, and 3 months after surgery associated with a follow up every 2 weeks over a year after surgery

06

What researchers measure

Primary outcomes

  1. Relative weight change at 1 year post-surgery of a craniopharyngioma

    Difference between the weight recorded at the last dietary consultation 1 year post-surgery and that recorded at the preoperative consultation, relative to the weight recorded at the preoperative consultation

    Time frame: 1 year

Secondary outcomes

  1. Relative weight change 15 days after surgery

    Difference between the weight recorded during the dietary consultation 15 days after surgery and that recorded during the preoperative consultation, relative to the weight recorded during the preoperative consultation

    Time frame: 15 days

  2. Relative weight change 3 months after surgery

    difference between the weight recorded during the dietary consultation 3 months after surgery and that recorded during the preoperative consultation, relative to the weight recorded during the preoperative consultation

    Time frame: 3 months

  3. Relative weight change 1 year after surgery

    Difference between the weight recorded during the dietary consultation 1 year after surgery and that recorded during the preoperative consultation, relative to the weight recorded during the preoperative consultation

    Time frame: 1 year

  4. Absolute weight change 15 days after surgery

    Difference between the weight recorded during the dietary consultation 15 days after surgery and that recorded during the preoperative consultation

    Time frame: 15 days

  5. Absolute weight change at 3 months post-surgery

    the difference between the weight recorded during the dietary consultation 3 months post-surgery and that recorded during the preoperative consultation

    Time frame: 3 months

  6. Absolute weight change at 1 year post-surgery

    the difference between the weight recorded during the dietary consultation 1 year post-surgery and that recorded during the preoperative consultation

    Time frame: 1 year

  7. Weight before surgery and then 15 days, 3 months, and 1 year after surgery

    Wheigh collecting on a weighing machine

    Time frame: 15 days, 3 months and 1 year

  8. Absolute change in BMI 15 days after surgery

    difference between the BMI recorded during the dietary consultation 15 days after surgery and that recorded during the preoperative consultation

    Time frame: 15 days

  9. Absolute change in BMI 3 months after surgery

    difference between the BMI recorded during the dietary consultation 3 months after surgery and that recorded during the preoperative consultation

    Time frame: 3 months

  10. Absolute change in BMI at 1 year after surgery

    difference between the BMI recorded during the dietary consultation 1 year after surgery and that recorded during the preoperative consultation

    Time frame: 1 year

  11. Relative change in BMI 15 days after surgery

    the difference between the BMI recorded during the dietary consultation 15 days after surgery and that recorded during the preoperative consultation, relative to that recorded during the preoperative consultation

    Time frame: 15 days

  12. Relative change in BMI at 3 months post-surgery

    difference between the BMI recorded during the dietary consultation 3 months post-surgery and that recorded during the preoperative consultation, relative to that recorded during the preoperative consultation

    Time frame: 3 months

  13. Relative change in BMI at 1 year after surgery

    the difference between the BMI recorded during the dietary consultation 1 year after surgery and that recorded during the preoperative consultation, relative to that recorded during the preoperative consultation

    Time frame: 1 year

  14. Percentage of patients who are overweight (BMI between 25 and 29.9 kg/m²) 15 days, 3 months and 1 year after surgery

    Number of patients in each BMI category (Calculation of BMI according to Quetelet's formula) 15 days, 3 months and 1 year after surgery

    Time frame: 15 days, 3 months and 1 year

  15. Percentage of patients in each BMI category according to the World Health Organisation classification at 15 days, 3 months and 1 year after surgery

    Number of patients in each BMI category according to the World Health Organisation classification (Calculation of BMI according to Quetelet's formula) at 15 days, 3 months and 1 year after surgery. Classification is as follow: * Normal: 18.5 to 24.9 kg/m², * Overweight: 25 to 29.9 kg/m², * Grade 1 obesity: 30 to 34.9 kg/m², * Grade 2 obesity: 35 to 39.9 kg/m², * Grade 3 obesity: 40 to 49.9 kg/m², * Grade 4 obesity: \> 50 kg/m²

    Time frame: 15 days, 3 months and 1 year

  16. Percentage of intermediate weight gain at each consultation

    Result of the calculation of divided the weight at today's consultation by the weight at the last consultation

    Time frame: 1 week or 15 days

  17. Percentage of patients presenting one or more biological abnormalities related to overweight or obesity (fasting blood glucose, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides) 15 days, 3 months, and 1 year after surgery

    Number of patients presenting one or more biological abnormalities related to overweight or obesity (fasting blood glucose, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides)

    Time frame: 15 days, 3 months, and 1 year

  18. Percentage of patients with abnormal fasting blood glucose levels 15 days, 3 months, and 1 year after surgery

    Number of patients with abnormal fasting blood glucose levels

    Time frame: 15 days, 3 months, and 1 year

  19. Percentage of patients with abnormal total cholesterol levels 15 days, 3 months, and 1 year after surgery

    Number of patients with abnormal total cholesterol levels

    Time frame: 15 days, 3 months, and 1 year

  20. Percentage of patients with abnormal HDL cholesterol levels 15 days, 3 months, and 1 year after surgery

    Number of patients with abnormal HDL cholesterol levels

    Time frame: 15 days, 3 months, and 1 year

  21. Percentage of patients with abnormal LDL cholesterol levels 15 days, 3 months, and 1 year after surgery

    Number of patients with abnormal LDL cholesterol levels

    Time frame: 15 days, 3 months, and 1 year

  22. Percentage of patients with abnormal triglyceride levels at 15 days, 3 months, and 1 year after surgery

    Number of patients with abnormal triglyceride levels

    Time frame: 15 days, 3 months, and 1 year

  23. Change in quality of life compared to the preoperative dietary consultation, 15 days, 3 months and 1 year after surgery

    Analysis of quality of life questionnaires (WHOQOL-BREF)

    Time frame: 15 days, 3 months and 1 year

  24. Total energy intake

    Assessment of total energy intake calculated from dietary intake, including proteins, lipids and carbohydrates.Unit of Measure: kcal

    Time frame: 15 days, 3 months and 1 year

  25. Questionnaire on eating behaviour and feelings about food (DEBQ), pre-operatively, then 15 days, 3 months and 1 year after surgery

    Analysis of the Dietary Behaviour and Eating Feelings Questionnaire (DEBQ)

    Time frame: 15 days, 3 months and 1 year

  26. Analysis of body composition (fat mass, lean mass) using an impedance meter (In Body device) 15 days, 3 months and 1 year after surgery

    Impedance measurement

    Time frame: 15 days, 3 months and 1 year

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07835165
Responsible party
Sponsor
First posted
Sep 22, 2026
Start date
Jan 1, 2027 (estimated)
Primary completion
Apr 1, 2030 (estimated)
Completion
Jul 1, 2030 (estimated)
Last update
Sep 22, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion